|
CMC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.252300E-02 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
7.286300E-02 |
| Stage1-vs-Stage3 |
1.757870E-02 |
| Stage1-vs-Stage4 |
8.073000E-01 |
| Stage2-vs-Stage3 |
2.077500E-02 |
| Stage2-vs-Stage4 |
8.986100E-02 |
| Stage3-vs-Stage4 |
3.032200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.75233219232996E-12 |
| Normal-vs-Asian |
3.83019999999901E-05 |
| Caucasian-vs-AfricanAmerican |
5.561600E-02 |
| Caucasian-vs-Asian |
9.707400E-01 |
| AfricanAmerican-vs-Asian |
4.220400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.555400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.32719987514463E-10 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
4.391400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.300600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.561000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.705000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.613600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.318800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.213800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.77219996852796E-09 |
| Normal-vs-Grade 2 |
1.11022302462516E-16 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.6242562850266E-12 |
| Grade 1-vs-Grade 2 |
4.431400E-01 |
| Grade 1-vs-Grade 3 |
6.030000E-01 |
| Grade 1-vs-Grade 4 |
9.369800E-01 |
| Grade 2-vs-Grade 3 |
6.527600E-01 |
| Grade 2-vs-Grade 4 |
4.157400E-01 |
| Grade 3-vs-Grade 4 |
5.987000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
1.514230E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.27279964345917E-10 |
| N0-vs-N1 |
2.102800E-01 |
|
|
